Search Results - "Faner, Rosa"

Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis by FANER, Rosa, ROJAS, Mauricio, MACNEE, William, AGUSTI, Alvar

“…Aging is a natural process characterized by progressive functional impairment and reduced capacity to respond appropriately to environmental stimuli and…”
Get full text

Precision medicine in airway diseases: moving to clinical practice by Agustí, Alvar, Bafadhel, Mona, Beasley, Richard, Bel, Elisabeth H, Faner, Rosa, Gibson, Peter G, Louis, Renaud, McDonald, Vanessa M, Sterk, Peter J, Thomas, Mike, Vogelmeier, Claus, Pavord, Ian D

“…On February 21, 2017, a European Respiratory Society research seminar held in Barcelona discussed how to best apply precision medicine to chronic airway…”
Get full text

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease by Lange, Peter, Celli, Bartolome, Agustí, Alvar, Boje Jensen, Gorm, Divo, Miguel, Faner, Rosa, Guerra, Stefano, Marott, Jacob Louis, Martinez, Fernando D, Martinez-Camblor, Pablo, Meek, Paula, Owen, Caroline A, Petersen, Hans, Pinto-Plata, Victor, Schnohr, Peter, Sood, Akshay, Soriano, Joan B, Tesfaigzi, Yohannes, Vestbo, Jørgen

“…It had been thought that most people with chronic obstructive pulmonary disease had normal lung function in mid-adult life and then lost it rapidly. In this…”
Get full text

Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis by Martinez-Garcia, Miguel Angel, Faner, Rosa, Oscullo, Grace, de la Rosa, David, Soler-Cataluña, Juan-Jose, Ballester, Marta, Agusti, Alvar

“…Treatment of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroids (ICS) is controversial, because it can reduce the risk of future…”
Get full text

The microbiome in respiratory medicine: current challenges and future perspectives by Faner, Rosa, Sibila, Oriol, Agustí, Alvar, Bernasconi, Eric, Chalmers, James D, Huffnagle, Gary B, Manichanh, Chaysavanh, Molyneaux, Philip L, Paredes, Roger, Pérez Brocal, Vicente, Ponomarenko, Julia, Sethi, Sanjay, Dorca, Jordi, Monsó, Eduard

“…The healthy lung has previously been considered to be a sterile organ because standard microbiological culture techniques consistently yield negative results…”
Get full text

Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype by Celli, Bartolome R, Locantore, Nicholas, Tal-Singer, Ruth, Riley, John, Miller, Bruce, Vestbo, Jørgen, Yates, Julie C, Silverman, Edwin K, Owen, Caroline A, Divo, Miguel, Pinto-Plata, Victor, Wouters, Emiel F M, Faner, Rosa, Agusti, Alvar

“…We tested whether emphysema progression accompanies enhanced tissue loss in other body compartments in 1817 patients from the ECLIPSE chronic obstructive…”
Get full text

Cellular Senescence in Lung Fibrosis by Hernandez-Gonzalez, Fernanda, Faner, Rosa, Rojas, Mauricio, Agustí, Alvar, Serrano, Manuel, Sellarés, Jacobo

“…Fibrosing interstitial lung diseases (ILDs) are chronic and ultimately fatal age-related lung diseases characterized by the progressive and irreversible…”
Get full text

COPD: algorithms and clinical management by Faner, Rosa, Agustí, Alvar

“…When you are invited to write an Editorial on a given paper, you are expected to provide a strong personal opinion that will both attract the readers' interest…”
Get full text

From systems biology to P4 medicine: applications in respiratory medicine by Noell, Guillaume, Faner, Rosa, Agustí, Alvar

“…Human health and disease are emergent properties of a complex, nonlinear, dynamic multilevel biological system: the human body. Systems biology is a…”
Get full text

Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema by Faner, Rosa, Cruz, Tamara, Casserras, Teresa, López-Giraldo, Alejandra, Noell, Guillaume, Coca, Ignacio, Tal-Singer, Ruth, Miller, Bruce, Rodriguez-Roisin, Roberto, Spira, Avrum, Kalko, Susana G, Agustí, Alvar

“…Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by a combination of airways disease (bronchiolitis) and…”
Get full text

Biomarkers, the control panel and personalized COPD medicine by Agusti, Alvar, Gea, Joaquim, Faner, Rosa

“…Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, so its clinical management needs to be personalized as much as possible…”
Get full text

Low birth weight as a potential risk factor for severe COVID-19 in adults by Crispi, Fàtima, Crovetto, Francesca, Larroya, Marta, Camacho, Marta, Tortajada, Marta, Sibila, Oriol, Badia, Joan Ramon, López, Marta, Vellvé, Kilian, Garcia, Ferran, Trilla, Antoni, Faner, Rosa, Blanco, Isabel, Borràs, Roger, Agustí, Alvar, Gratacós, Eduard

“…The identification of factors predisposing to severe COVID-19 in young adults remains partially characterized. Low birth weight (LBW) alters cardiovascular and…”
Get full text

Pathophysiology and genomics of bronchiectasis by Perea, Lidia, Faner, Rosa, Chalmers, James D, Sibila, Oriol

“…Bronchiectasis is a complex and heterogeneous inflammatory chronic respiratory disease with an unknown cause in around 30-40% of patients. The presence of…”
Get full text

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge by Sibila, Oriol, Perea, Lídia, Albacar, Núria, Moisés, Jorge, Cruz, Tamara, Mendoza, Núria, Solarat, Belen, Lledó, Gemma, Espinosa, Gerard, Barberà, Joan Albert, Badia, Joan Ramon, Agustí, Alvar, Sellarés, Jacobo, Faner, Rosa

“…Some COVID-19 survivors present lung function abnormalities during follow-up, particularly reduced carbon monoxide lung diffusing capacity (DLCO). To…”
Get full text

Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study by Mendoza, Nuria, Rivas, Eva, Rodriguez-Roisin, Roberto, Garcia, Tamara, Bruguera, Miquel, Agusti, Alvar, Faner, Rosa

“…The hepatopulmonary syndrome (HPS) is defined by the presence of pulmonary gas exchange abnormalities due to intrapulmonary vascular dilatations in patients…”
Get full text

Author Correction: Pulmonary vascular reactivity in growth restricted fetuses using computational modelling and machine learning analysis of fetal Doppler waveforms by Vellvé, Kilian, Garcia‑Canadilla, Patricia, Nogueira, Mariana, Youssef, Lina, Arranz, Angela, Nakaki, Ayako, Boada, David, Blanco, Isabel, Faner, Rosa, Figueras, Francesc, Agustí, Àlvar, Gratacós, Eduard, Crovetto, Francesca, Bijnens, Bart, Crispi, Fàtima

Get full text

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD) by Cruz, Tamara, López-Giraldo, Alejandra, Noell, Guillaume, Casas-Recasens, Sandra, Garcia, Tamara, Molins, Laureano, Juan, Manel, Fernandez, Marco A, Agustí, Alvar, Faner, Rosa

“…Chronic Obstructive Pulmonary Disease (COPD) is associated with an abnormal pulmonary and systemic immune response to tobacco smoking. Yet, how do immune cells…”
Get full text

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression by Mendoza, Nuria, Casas-Recasens, Sandra, Olvera, Núria, Hernandez-Gonzalez, Fernanda, Cruz, Tamara, Albacar, Núria, Alsina-Restoy, Xavier, Frino-Garcia, Alejandro, López-Saiz, Gemma, Robres, Lucas, Rojas, Mauricio, Agustí, Alvar, Sellarés, Jacobo, Faner, Rosa

“…(1) The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial. We hypothesized that peripheral blood…”
Get full text

Pulmonary vascular reactivity in growth restricted fetuses using computational modelling and machine learning analysis of fetal Doppler waveforms by Vellvé, Kilian, Garcia-Canadilla, Patricia, Nogueira, Mariana, Youssef, Lina, Arranz, Angela, Nakaki, Ayako, Boada, David, Blanco, Isabel, Faner, Rosa, Figueras, Francesc, Agustí, Àlvar, Gratacós, Eduard, Crovetto, Francesca, Bijnens, Bart, Crispi, Fàtima

“…The aim of this study was to investigate the pulmonary vasculature in baseline conditions and after maternal hyperoxygenation in growth restricted fetuses…”
Get full text

Lung immune signatures define two groups of end-stage IPF patients by Cruz, Tamara, Mendoza, Núria, Casas-Recasens, Sandra, Noell, Guillaume, Hernandez-Gonzalez, Fernanda, Frino-Garcia, Alejandro, Alsina-Restoy, Xavi, Molina, María, Rojas, Mauricio, Agustí, Alvar, Sellares, Jacobo, Faner, Rosa

“…Abstract Background The role of the immune system in the pathobiology of Idiopathic Pulmonary Fibrosis (IPF) is controversial. Methods To investigate it, we…”
Get full text